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Table S1. Summary of primary and secondary packages of interventions in each country setting, by 
age where applicable 
Setting List of constituent interventions 
Kenya Primary interventions 
 HIV Testing and Counselling (age 10-24) 
 Social asset building (age 10-24) 
 School-based HIV and violence prevention (age 10-24) 
 Financial capability training (age 10-24) 
 Entrepreneurship training (age 15-24) 
 Condom education and promotion (age 15-24) 
 Contraceptive method mix education and counselling (age 15-24) 
 PrEP education and counselling (age 18-24) 
Secondary interventions (needs based) 
 Families Matter Programme (age 10-14) 
 Educational subsidies (age 10-24) 
 Post violence care (age 10-24) 
 Cash transfers (age 15-24) 
 Combined socio-economic approaches (age 15-24) 
 Condom provision (age 15-24) 
 Contraceptive method mix provision (age 15-24) 
 PrEP provision (age 18-24) 
South Africa Primary interventions 
 School-based HIV and violence prevention (age 10-19) 
 Social asset building (age 10-19) 
 Condoms (sexually active age 10-24) 
 HIV Testing and Counselling (sexually active age 10-24) 
 Sexual and reproductive health (sexually active age 10-24) 
Secondary interventions  (needs based)  
 Material support e.g. cash transfers and educational subsidies (age 10-
19) 
 Post violence care (age 10-24) 
 Combined socio-economic approaches (age 10-24) 
 PrEP (age 18-24) 
Zimbabwe* Primary interventions 
 HIV Testing and Counselling (age 15-24) 
 Condom promotion and provision (age 15-24) 
 Social asset building (age 15-24) 
Secondary interventions (needs based) 
 Disability assessment (age 15-24) 
 Education support or combination socio-economic approaches (age 15-
24) 
 Family planning services (age 15-24) 
 Gender based violence response (age 15-24) 
 Health services (other STIs) (age 15-24) 
 PrEP (age 15-24) 
*’KP_Prev’ – PEPFAR indicator for the DREAMS package of HIV prevention services for key 
populations [19] 
Table S2. Estimated sample sizes to measure change over time in secondary outcomes among AGYW 
Key outcomes of interest  
for AGYW 
15-19 year old adolescent girls 20-24 year old young  women 









































Proportion of AGYW who 
know their HIV status 
20% 50% 2.50 45 58 385 1537 30% 60% 2.00 49 63 257 1476 
30% 60% 2.00 49 63 257 1476 40% 70% 1.75 49 63 165 1291 
40% 70% 1.75 49 63 165 1291 50% 80% 1.60 45 58 97 984 
50% 80% 1.60 45 58 97 984 60% 90% 1.50 38 49 43 554 
Proportion of AGYW who 
have ever had sex 
45% 20% 0.44 62 80 1537 984 85% 40% 0.47 22 27 577 1476 
  30% 0.67 176 230 897 1291   50% 0.59 33 42 385 1537 
50% 25% 0.50 66 85 1153 1153 90% 45% 0.50 20 25 470 1522 
55% 30% 0.55 68 88 897 1291 95% 50% 0.53 19 23 385 1537 
Proportion of AGYW 
[aged 18-19] who first 
had sex aged <18 years 
40% 20% 0.50 91 119 1537 984          
  30% 0.75 376 496 897 1291          
50% 30% 0.60 103 134 897 1291          
60% 40% 0.67 107 140 577 1476          
Proportion of AGYW who 
used a condom last time 
they had sex, during the 
past 12 months 
5% 40% 8.00 27 34 577 1476 5% 40% 8.00 27 34 577 1476 
  20% 4.00 88 114 1537 984   20% 4.00 88 114 1537 984 
10% 45% 4.50 30 38 470 1522 10% 45% 4.50 30 38 470 1522 
15% 50% 3.33 33 42 385 1537 15% 50% 3.33 33 42 385 1537 
Proportion of AGYW who 
had >1 sexual partner 
during the past 12 
2% 1% 0.50 2515 3300 38032 61 2% 1% 0.50 2515 3300 38032 61 
5% 2.5% 0.50 984 1291 14983 150 5% 2.5% 0.50 984 1291 14983 150 
‡Post-DREAMS vs pre-DREAMS prevalence 
†Sample size required to estimate the post-DREAMS prevalence to within ±10% of the point estimate 
(“relative” precision) 
βSample size required to estimate the post-DREAMS prevalence to within ±2.5 percentage points 
(“absolute” precision) 
Footnote: The sample sizes refer to the numbers required both pre-DREAMS and again post-DREAMS. 
 
  
months 10% 5% 0.50 474 621 7300 292 10% 5% 0.50 474 621 7300 292 
15% 7.5% 0.50 304 398 4738 427 15% 7.5% 0.50 304 398 4738 427 
Proportion of AGYW 
[aged 18-19]  pregnant 
before age 18 
15% 7.5% 0.50 304 398 4738 427          
  10% 0.67 726 957 3458 554          
20% 10% 0.50 219 286 3458 554          
25% 12.5% 0.50 168 219 2690 673          
Proportion of AGYW who 
had a sexual partner >5 
years older/younger in 
the past 12m 
20% 10% 0.50 219 286 3458 554 50% 25% 0.50 66 85 1153 1153 
30% 15% 0.50 134 174 2177 784 60% 30% 0.50 49 63 897 1291 
40% 20% 0.50 91 119 1537 984 70% 35% 0.50 37 47 714 1399 
Proportion of AGYW who 
have ever experienced 
sexual abuse/violence 
10% 5% 0.50 474 621 7300  10% 5% 0.50 474 621 7300  
15% 7.5% 0.50 304 398 4738  20% 10% 0.50 219 286 3458  
20% 10% 0.50 219 286 3458  30% 15% 0.50 134 174 2177  
Proportion of AGYW 
[aged 18-19] who are in 
or have completed 
school 
30% 50% 1.67 103 134 385           
  40% 1.33 376 496 577           
40% 60% 1.50 107 140 257           
50% 70% 
1.40
0 103 134 42 
 
      
 























24 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 70% 1.75 49 63 165 1291 
  80% 2.00 28 35 97 984 
 50% 80% 1.60 45 58 97 984 
  90% 1.80 25 31 43 554 
25-
34 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 75% 1.50 66 85 129 1153 
  85% 1.70 33 42 68 784 
 60% 80% 1.33 91 119 97 984 
  90% 1.50 38 49 43 554 
35-
44 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 75% 1.50 66 85 129 1153 
  85% 1.70 33 42 68 784 
 60% 80% 1.33 91 119 97 984 
  90% 1.50 38 49 43 554 
45- 40% 65% 1.63 70 90 207 1399 
54 
  75% 1.88 36 46 129 1153 
 50% 75% 1.50 66 85 129 1153 
  85% 1.70 33 42 68 784 
 60% 80% 1.33 91 119 97 984 
  90% 1.50 38 49 43 554 
25-
54 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 75% 1.50 66 85 129 1153 
  85% 1.70 33 42 68 784 
 60% 80% 1.33 91 119 97 984 









24 20% 50% 2.50 45 58 385 1537 
  60% 3.00 28 35 257 1476 
 30% 50% 1.67 103 134 385 1537 
  60% 2.00 49 63 257 1476 
 40% 60% 1.50 107 140 257 1476 
  70% 1.75 49 63 165 1291 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
25-
34 30% 50% 1.67 103 134 385 1537 
  60% 2.00 49 63 257 1476 
 40% 60% 1.50 107 140 257 1476 
  70% 1.75 49 63 165 1291 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
35-
44 30% 50% 1.67 103 134 385 1537 
  60% 2.00 49 63 257 1476 
 40% 60% 1.50 107 140 257 1476 
  70% 1.75 49 63 165 1291 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
45-
54 30% 50% 1.67 103 134 385 1537 
  60% 2.00 49 63 257 1476 
 40% 60% 1.50 107 140 257 1476 
  70% 1.75 49 63 165 1291 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
25-
54 30% 50% 1.67 103 134 385 1537 
  60% 2.00 49 63 257 1476 
 40% 60% 1.50 107 140 257 1476 
  70% 1.75 49 63 165 1291 
 50% 70% 1.40 103 134 165 1291 




24 20% 50% 2.50 45 58 385 1537 
HIV+ males 
in past 12 
months 
  60% 3.00 28 35 257 1476 
 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 70% 1.75 49 63 165 1291 
  80% 2.00 28 35 97 984 
25-
34 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
35-
44 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
45-
54 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
25-
54 30% 60% 2.00 49 63 257 1476 
  70% 2.33 29 36 165 1291 
 40% 65% 1.63 70 90 207 1399 
  75% 1.88 36 46 129 1153 
 50% 70% 1.40 103 134 165 1291 
  80% 1.60 45 58 97 984 
t-DREAMS vs pre-DREAMS prevalence. 
†Sample size required to estimate the post-DREAMS prevalence to within ±10% of the point estimate 
(“relative” precision) 
βSample size required to estimate the post-DREAMS prevalence to within ±2.5 percentage points 
(“absolute” precision) 
Footnote: The sample sizes for VMMC among HIV- males refer to the numbers required for analysis 
however the prevalence of HIV needs to be taken into account for the actual number needed to sample. 
Similarly, the figures for uptake of ART among HIV+ males represent the numbers required for analysis 
before accounting for HIV prevalence. If HIV prevalence is 10% the number needed to sample size will 
be 10 times larger since only 10% of those sampled would be HIV+; if prevalence is 20% the actual 
number needed to sample will be 5 times larger. 
Table S4. Estimated sample sizes to assess the causal effect of key ‘mediators of change’ on secondary 




Prevalence of outcome at 24 
months 








90% 10% 10% 7.5% 0.75 15001 19523 
    5% 0.50 3536 4444 
    2.5% 0.25 1447 1736 
   30% 20% 0.67 2244 2899 
    15% 0.50 973 1229 
    10% 0.33 528 647 
   50% 30% 0.60 721 928 
    20% 0.40 317 397 
    10% 0.20 171 204 
   70% 40% 0.57 321 416 
    30% 0.43 184 234 
    20% 0.29 119 146 
   90% 60% 0.67 219 294 
    50% 0.56 137 182 
    40% 0.44 94 123 
70% 30% 10% 7.5% 0.75 6321 8301 
    5% 0.50 1469 1886 
    2.5% 0.25 598 744 
   30% 20% 0.67 949 1238 
    15% 0.50 411 526 
    10% 0.33 223 279 
   50% 30% 0.60 311 401 
    20% 0.40 138 174 
    10% 0.20 76 92 
   70% 40% 0.57 144 186 
    30% 0.43 86 107 
    20% 0.29 54 67 
   90% 60% 0.67 107 138 
    50% 0.56 69 88 
    40% 0.44 49 62 
50% 50% 10% 7.5% 0.75 5211 6906 
    5% 0.50 1186 1553 
    2.5% 0.25 473 608 
   30% 20% 0.67 783 1031 
    15% 0.50 336 436 
    10% 0.33 181 231 
   50% 30% 0.60 258 336 
    20% 0.40 113 146 
    10% 0.20 63 78 
   70% 40% 0.57 123 158 
    30% 0.43 73 91 
    20% 0.29 48 58 
   90% 60% 0.67 96 123 
    50% 0.56 63 78 
    40% 0.44 43 53 
30% 70% 10% 7.5% 0.75 6076 8131 
    5% 0.50 1343 1797 
    2.5% 0.25 513 684 
   30% 20% 0.67 913 1213 
    15% 0.50 384 509 
    10% 0.33 201 268 
   50% 30% 0.60 306 397 
    20% 0.40 131 172 
    10% 0.20 72 88 
   70% 40% 0.57 147 188 
    30% 0.43 84 109 
    20% 0.29 56 68 
   90% 60% 0.67 122 147 
    50% 0.56 76 93 
    40% 0.44 56 63 
10% 90% 10% 7.5% 0.75 13863 18726 
    5% 0.50 2951 4038 
    2.5% 0.25 1051 1463 
   30% 20% 0.67 2076 2788 
    15% 0.50 851 1151 
    10% 0.33 426 576 
   50% 30% 0.60 688 913 
    20% 0.40 288 376 
    10% 0.20 138 188 
   70% 40% 0.57 338 426 
    30% 0.43 188 238 
    20% 0.29 113 151 
   90% 60% 0.67 276 338 
    50% 0.56 176 213 
    40% 0.44 126 138 
†Figures inflated by dividing by 0.8 in order to allow for 20% loss to follow-up 
 
 
